The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Protracted Daily Administration of Temozolomide Is Feasible: A Phase I and Pharmacokinetic - Pharmacodynamic Study.
 
Isabel Preeshagul
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Dava Oncology; DAVA Pharmaceuticals; G1 Therapeutics; Genentech; IDEOlogy Health; IDEOlogy Health; Intellisphere; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Jazz Pharmaceuticals; MDoutlook; Novartis; OncLive/MJH Life Sciences; PER; pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Takeda
 
Devika Das
Consulting or Advisory Role - Boehringer Ingelheim
 
Andrea Arfe
No Relationships to Disclose
 
Mark Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Coherus Biosciences; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Jill Feldman
Honoraria - Mariana Oncology
Consulting or Advisory Role - AstraZeneca; Johnson & Johnson/Janssen; Troper Wojcicki Foundation/23&Me LCGS
Travel, Accommodations, Expenses - J&J; Mariana Oncology
 
Terri Conneran
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Mirati Therapeutics (I); Revolution Medicines (I)
Honoraria - AstraZeneca; Bayer; Novartis; Qiagen; Revolution Medicines; Sanofi
Consulting or Advisory Role - Mirati Therapeutics; Revolution Medicines; Roche/Genentech
Travel, Accommodations, Expenses - Amgen (I); AstraZeneca; Frontier Medicines; Novartis; Sanofi
 
Marcia Horn
No Relationships to Disclose
 
Eric Singhi
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb/Roche; Janssen; Lilly; Novocure; Regeneron
 
Robert Daly
Stock and Other Ownership Interests - CVS Health (I); Lilly (I); Roche/Genentech
Consulting or Advisory Role - Varian Medical Systems
 
Antoinette Wozniak
Consulting or Advisory Role - AstraZeneca
 
Cardinale Smith
Honoraria - AstraZeneca
Consulting or Advisory Role - Daymark; Elevance Health
Speakers' Bureau - GlaxoSmithKline; Teva
 
Ishwaria Subbiah
Consulting or Advisory Role - MedImmune (I)
Research Funding - Abbvie (I); Amgen (I); Bayer (I); Blueprint Medicines (I); Celgene (I); Exelixis (I); Fujifilm (I); GlaxoSmithKline (I); Incyte (I); Loxo (I); Multivir (I); NanoCarrier (I); Northwest Biotherapeutics (I); Novartis (I); Pfizer (I); Takeda (I)
Travel, Accommodations, Expenses - AstraZeneca